How to Choose a Beta-Blocker

You will be listening to one of our many editorial discussions. This one took place on September 12, 2017 and is led by our Editor, Sherri Boehringer, PharmD, BCPS. You’ll hear the voices of Editorial Board members Steven E. Nissen, MD, MACC, Cleveland Clinic; Craig D. Williams, PharmD, FNLA, BCPS, Oregon Health & Science University; Douglas S. Paauw, MD, MACP, University of Washington Medical Center; and Andrea Darby-Stewart, MD, HonorHealth Family Medicine Residency, Arizona. You’ll also listen to cardiologist and heart failure guidelines author, Clyde W. Yancy, MD, MSc, MACC, FAHA, MACP, FHFSA, Northwestern University, Chicago. You can read our brief, to-the-point Recommendation and dive into the evidence-based details if you wish.

Get in on future discussions

The PL Voices audio snippet above is brief. It is taken from the full hour-long session we hold every month. We call these sessions PL Voices - Clinical Recommendations. You are invited to join any of them. Plus you can participate if you want, by asking questions or making suggestions during the discussion.

You also get CME credit for each full session. To start attending so you can get the inside scoop first, you need to become a Prescriber's Letter Platinum Member.

I am a PL Platinum member. Register me for upcoming sessions at no charge.

Upgrade me to Platinum Member, so that I can attend all future sessions, live or on-demand.

I would like to be invited to an upcoming session to see what the buzz is about.

Related Articles